Informação sobre produto
- Benzamide, N-[(2S)-4-[4-(acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methyl-
- Benzamide, N-[4-[4-(acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methyl-, (S)-
- N-[(2S)-4-[4-(Acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
- N-[(2S)-4-[4-(acetylamino)-4-phenylpiperidin-1-yl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
- Sr 48968
- Sr 48968C
Saredutant is a potent, selective, and orally bioavailable antagonist of the glucocorticoid receptor. This drug has been approved for the treatment of IBD (inflammatory bowel disease) in Japan. Saredutant has also been shown to be effective for treating cancer and bowel disorders that are induced by inflammation. Saredutant is a potent anti-inflammatory agent that inhibits neutrophil infiltration into the inflamed bowel mucosa and reduces mucosal edema. It also inhibits CD4+ T cells from producing proinflammatory cytokines such as IL-2, IFN-γ, and TNF-α. Saredutant has been shown to reduce systolic blood pressure in animal studies, suggesting that it may have antihypertensive effects.
Propriedades químicas
Consulta técnica sobre: 3D-SFA00163 Saredutant
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
